National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.
Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, James AH, Laraque D, Mendez M, Montoya CJ, Pollock BH, Robinson L, Scholnik AP, Schori M.
Ann Intern Med. 2008 Jun 17;148(12):932-8. Epub 2008 May 5. No abstract available. PMID: 18458271 [PubMed - indexed for MEDLINE]Related articlesFree article